“Treatment Outcomes of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-Transporter-2 Inhibitors in Diabetes Mellitus with Poor Glycemic Control” (2024) Journal of Medicine, 25(2), pp. 107–114. doi:10.3329/jom.v25i2.74306.